drugset / Trial / NCT04486859

Postoperative Thrombosis Prevention in Patients With CD

NCT04486859

Active not recruiting 206 enrolled Huashan Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Patients with Cushing disease was randomized to 2 groups. After surgery, the patients were managed with mechanical prevention or mechanical prevention plus anticoagulant drugs(LMWH followed by rivaroxaban), VTE was observed 24h, 5day, 4weeks and 12weeks after surgery.Bleeding events were also recorded.

Timeline

Start
2020-12-01
Primary completion
2025-05-01
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivaroxaban Other / unclassified